Larotrectinib in NTRK3 fusion–positive metastatic secretory carcinoma of the breast: A case study
Triple-negative breast cancer (TNBC) is an aggressive heterogeneous form of breast cancer that accounts for 15 %-20 % of all breast cancers. Characterized by an absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, TNBCs are often treated with...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Current Problems in Cancer: Case Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666621924000565 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|